Enjoy complimentary customisation on priority with our Enterprise License!
The global Kidney Stones Therapeutic market size is forecasted to increase by USD 566.78 million at a CAGR of 5.42% between 2022 and 2027. The growth of the market depends on several factors, including the growing popularity of flexible digital ureteroscopes, the rising incidence of urolithiasis, and the increasing prevalence of kidney stone disease.
To learn more about this report, Download Report Sample
This report extensively covers market segmentation by type (ureteroscopy, lithotripsy, and percutaneous nephrolithotomy (PCNL)), end-user (hospitals, specialty clinics, and ambulatory surgical centers), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
The market growth by the ureteroscopy segment will be significant during the forecast period. Ureteroscopy, which is also known as intracorporeal lithotripsy and retrograde intrarenal surgery (RIRS), is used if the stone size is up to 15 mm-20 mm in diameter and has moved into the ureter. This procedure has a high success rate when compared to lithotripsy.
Get a glance at the market contribution of various segments Request a PDF Sample
The ureteroscopy segment was valued at USD 772.74 million in 2017 and continued to grow by 2021. Vendors in the US offer technologically advanced ureteroscopes. For instance, Boston Scientific Corporation offers LithoVue single-use digital flexible ureteroscope, which delivers detailed high-resolution digital images. The use of single-use digital ureteroscopes in hospitals and clinics has increased when compared to reusable ureteroscopes due to the high capital expense of buying reusable ureteroscopes. The number of ureteroscopy procedures is estimated to account for more than half of the kidney stone treatment surgeries performed worldwide. Therefore, the URS segment is expected to dominate the global s market during the forecast period.
The rising incidence of urolithiasis is notably driving the market growth, although factors such as the shortage of skilled professionals may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Driver
Significant Trend
Major Challenge
Key Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Anvik Biotech - The company offers a kidney stone therapeutic, namely Pitonac.
Intas Pharmaceuticals Ltd.- The company offers CNS, Cardiovascular, Diabetology, Gastroenterology, Urology, and Oncology medical products.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The North American market growth is attributed to high demand for superior medical technology, increasing adoption of minimally invasive treatment options such as URS, the region's existing advanced medical infrastructure, and strong market presence of major providers.
In Canada, approximately 100,000 people out of every million will develop kidney stones at some point in their lives. Increasing public and private healthcare spending is also boosting the market growth. Moreover, the proportion of medical expenditures spent on treating kidney stones is steadily increasing in the region. North America dominates the market in terms of revenue and is expected to maintain its position over the forecast period. Canada accounts the large share of the North American market due to the rising prevalence of kidney stone disease, demand for high-quality medical technology, and increasing investment in the development of advanced.
Kidney stones, including calcium oxalate stones, uric acid stones, struvite stones, and cystine stones, present a significant healthcare concern globally. Diagnosis methods such as ultrasound, CT scans, and X-rays play a crucial role in identifying these stones, enabling treatment decisions. Treatment options range from medications to minimally invasive procedures like shock wave lithotripsy and ureteroscopy.
As the prevalence of kidney stones rises, driven by factors like fast food consumption and demographic shifts such as the aging population, there's a growing demand for therapeutic solutions. This trend has led to technological advancements in medical devices and diagnostic tools, facilitating minimally invasive surgical procedures. However, challenges such as high treatment costs and the recurrence of kidney stones remain, prompting ongoing efforts in research and development. Recent innovations, like Dornier MedTech's OptiVision technology, aim to address these challenges, enhancing the efficacy and accessibility of kidney stone treatment worldwide.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Kidney Stones Therapeutic Market Scope |
|
Report Coverage |
Details |
Page number |
161 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.42% |
Market growth 2023-2027 |
USD 566.78 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
4.5 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Anvik Biotech, Aristo Pharma GmbH, Bausch Health Co Inc., Biomedix Siomond Pharma, Cipla Ltd., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Walter Bushnell, Windlas Biotech Pvt. Ltd., Worth Medicines Pvt. Ltd., Pfizer Inc., and Bayer AG |
Market dynamics |
Parent market analysis, Market forecasting, Market growth and forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our market trends and analysis report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Request Market Research Report PDF sample
We can help! Our analysts can customize this market report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.